Magnesium is a key cofactor in glucose metabolism, influencing insulin secretion and insulin sensitivity. Epidemiological studies consistently link low serum magnesium with higher fasting glucose and increased risk of type 2 diabetes. However, the evidence from randomized controlled trials is mixed; some show modest improvements in glycemic control with magnesium supplementation, particularly in individuals with deficiency or insulin resistance. The effect size is small and not sufficient to recommend magnesium as a standalone treatment for blood sugar issues. Dietary sources (whole grains, nuts, leafy greens) are preferred. High-dose supplements can cause gastrointestinal side effects and are contraindicated in renal impairment without medical supervision. In summary, magnesium plays a supportive role in blood sugar regulation, but its impact is modest and context-dependent. Consumers should not rely on genetic or biomarker tests alone to guide magnesium use; clinical assessment of magnesium status is more reliable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-9e7ed1f31040f20d6966d283